BME2025 Mechanical Circulatory Support Forum: Advancing Frontiers and Exploring New Breakthroughs in Cardiovascular Therapy

2025China Biomedical Engineering Conference and Innovative Healthcare Summit (BME2025) in6Month21 - 23Successfully held in Suzhou. As a highly anticipated key segment of the conference, the Mechanical Circulatory Support Forum brought together authoritative experts, research elites, and corporate representatives from the field of cardiovascular medicine both in China and abroad. They conducted in-depth and comprehensive discussions on the crucial area of mechanical circulatory support technology, injecting strong momentum into the innovative development of cardiovascular disease treatment.

At the opening of the conference, Professor Hu Shengshou, Academician of Fuwai Hospital and Chairman of the Congress, delivered an enthusiastic welcome speech with profound academic attainments and industry insights. He stated:“At present, mechanical circulatory assist technology is increasingly becoming the focus of the industry. Its gradual application in clinical practice is bringing hope to countless patients.‘Heart’The Light of Hope.”

During the forum, representatives from magAssist (Suzhou) Co., Ltd. (hereinafter referred to as“magAssist”) Dr. Xu Jiahao sharedNyokAssist®The phased achievements of the transcatheter ventricular assist device. This device is a new-generation interventional pump developed through the integration of medical and engineering innovations by the team of Academician Ge Junbo from Zhongshan Hospital, Fudan University, in collaboration with magAssist, responding to the national call.

Dr. Xu Jiahe introduced in detailNyokAssist®Multiple Technical Advantages:

1. Interventional size reduced to9Fr(Run-time extensible to21Fr), can provide greater than3.5L/minThe average flow and greater than5L/minThe peak flow rate, smaller size helps reduce vascular complications;
   

2. The flexible outflow tract design does not affect the closure of the main cusp, reducing the impact of the transcatheter pump on the motion of the main cusp;

3. Based on Computational Fluid Dynamics (CFD) The simulation optimized the pump design for hydraulic performance and hemocompatibility, eliminating low-speed areas in the flow path and optimizing shear stress distribution to minimize residence time. Through optimization,NyokAssist®The interventional pump simultaneously achieves high hydraulic output and high hemocompatibility;

4. The external motor design avoids the problems of hemolysis and thrombosis caused by the heating of internal motors and significantly reduces the cost of single-use consumables.

   
   

Animal experimental results show that,NyokAssist®The transcatheter ventricular assist device is easy to operate, with smooth navigation through the aortic arch and across the valve. It demonstrates excellent performance in several critical physiological indicators such as blood compatibility, liver, and kidney function. This device can effectively enhance the circulatory function of the cardiovascular system and increase the mean arterial pressure (MAP), while reducing pulse pressure. In terms of hemodynamics, it can effectively reduce the left ventricular end-diastolic volume (LVEDV), reduce the cardiac workload of patients, and maintain circulatory stability. Preliminary data from phased clinical trials have confirmed this.NyokAssist®Safety and Efficacy of Transcatheter Ventricular Assist Devices.

NyokAssist®Transcatheter Ventricular Assist Device is a model of innovation in the medical industry empowered by interdisciplinary collaboration. Its innovative foldable impeller, external motor, and optimized hydrodynamic design not only significantly reduce surgical risks but also fill a critical gap in high-risk cases in China.PCIThe technical gap in intraoperative circulatory support has won dual innovation awards in China and the US. This breakthrough confirms the core value of interdisciplinary integration between medical and engineering fields.——Through the deep coupling of clinical needs and engineering technology, promote China-produced high-end medical equipment from“Following”To“Leading the Way”A leap forward, transforming medical challenges into industrial innovation momentum, and injecting a strong engine for the vigorous development of new quality productivity in the life and health field.

- END -